Clinical Trial Update: Extension Study of NS-089/NCNP-02 in DMD [Phase 2]

View source ↗

Summary

The extension study of NS-089/NCNP-02 for Duchenne muscular dystrophy is described as a Phase 2 trial. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• NS-089/NCNP-02

Snippet

Sponsor: Nippon Shinyaku Co., Ltd. | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING